FDA Unveils Draft Guidances on Innovative Trial Design

The FDA Friday issued two new draft guidances — one on adaptive clinical trials and the other on master protocol designs — that it hopes will help sponsors innovate and get treatments to market more swiftly and efficiently.
Source: Drug Industry Daily